Lower airways bacterial profile in healthy subjects and COPD. A meta-analytical review of protected specimen brush studies Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
A network analysis of clinical characteristics of patients with COPD: partial results. Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006
Comparison of induced sputum samples, versus BAL samples in detection of the microbial load among children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
A comparative study of conventional preparation, thin prep and cell block in cytologic specimens of lung diseases Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004
Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
Repeatability of inflammatory analysis in induced sputum samples in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Bacterial load in induced sputum from acute asthma (preliminary results) Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002
The microbiome of COPD in protected, bronchoscopic airway samples Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Should samples taken at bronchoscopy be sent for microscopy and culture sensitivity (MC&S) if no obvious evidence of infection is seen? Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer Year: 2010
Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019
Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Morphological changes of large bronchi in sarcoidosis (analysis of biopsy specimens) Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Additional analysis of a longitudinal study at two pooled cohorts of salt miners with mixed model analysis Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008
Comparison of different sputum examination methods to determine time for discontinuation of respiratory isolation for tuberculosis patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
One year stability and sex differences in a 5 path analysis of the normal human airway tree via QCT: SPIROMICS cohort Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016
Comparison of the results of gram stain and non-specific cultures in sputum collected from patients with lower respiratory tract infections Source: Eur Respir J 2004; 24: Suppl. 48, 187s Year: 2004